Closed Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The Centers for Disease Control and Prevention (CDC) plans to award a sole-source contract to the University of California Los Angeles Fielding School of Public Health for MPOX immunogenicity and seroprevalence services. The contract will be a firm fixed-price purchase order with a performance period from June 1, 2024, to May 31, 2028. The decision to sole-source is based on the unique capabilities of the University of California Los Angeles Fielding School of Public Health in providing the required services.
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to University of California Los Angeles Fielding School of Public Health. The period of performance will be 06/01/2024 to 05/31/2028. Justification of the capability required is provided on the sole source justification document. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 6.302-1 and 10 U.S.C. 3204(a)(1). This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist Iris Gonzalez at qsx8@cdc.gov by COB 5pm, est April 24, 2024.
NOTICE OF INTENT TO SOLE SOURCE MPOX IMMUNOGENICITY AND SEROPREVALENCE is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.